UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 180

Sortiert nach

Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China

Annals of oncology, 2019-10, Vol.30 (10), p.1630-1637

2019

Volltextzugriff (PDF)

Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer

Annals of oncology, 2019-02, Vol.30 (2), p.266-273

2019

Volltextzugriff (PDF)

73P A novel nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer

Annals of oncology, 2022-04, Vol.33, p.S64

2022

Volltextzugriff (PDF)

Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial

Annals of oncology, 2021-01, Vol.32 (1), p.85-96

2021

Volltextzugriff (PDF)

NGS-based profiling reveals a critical contributing role of somatic D-loop mtDNA mutations in HBV-related hepatocarcinogenesis

Annals of oncology, 2019-06, Vol.30 (6), p.953-962

2019

Volltextzugriff (PDF)

284P Gut microbiota mediates the protective effects of resveratrol against the intestinal barrier dysfunction in non-alcoholic steatohepatitis induced by high-fat diet

Annals of oncology, 2022-11, Vol.33, p.S1543-S1543

2022

Volltextzugriff (PDF)

Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma

Annals of oncology, 2014-12, Vol.25 (12), p.2413-2419

2014

Volltextzugriff (PDF)

Phase I dose escalation and expansion study of golidocitinib, a highly selective JAK1 inhibitor, in relapsed or refractory peripheral T-cell lymphomas

Annals of oncology, 2023-11, Vol.34 (11), p.1055-1063

2023

Volltextzugriff (PDF)

180P Schwann cells promotes tumour progression in small cell lung cancer

Annals of oncology, 2022-04, Vol.33, p.S113-S114

2022

Volltextzugriff (PDF)

226P Prognosis stratification of immunotherapy by a mutational signature in urothelial carcinoma

Annals of oncology, 2023-11, Vol.34, p.S1563

2023

Volltextzugriff (PDF)

Biomarker assessment of the CBCSG006 trial: a randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer

Annals of oncology, 2018-08, Vol.29 (8), p.1741-1747

2018

Volltextzugriff (PDF)

Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches

Annals of oncology, 2016-09, Vol.27 (9), p.1706-1712

2016

Volltextzugriff (PDF)

103P Comprehensive genomic landscape in younger and older Chinese patients with colorectal cancer

Annals of oncology, 2020-11, Vol.31, p.S1281-S1281

2020

Volltextzugriff (PDF)

1482P Comprehensive molecular profiling and identification of prognostic factors in patients with resectable esophageal squamous cell carcinoma

Annals of oncology, 2020-09, Vol.31, p.S923-S923

2020

Volltextzugriff (PDF)

P53-5 Severe hypercalcemia in renal cell carcinoma: The diverse manifestations of genitourinary malignancies

Annals of oncology, 2021-07, Vol.32, p.S358-S358

2021

Volltextzugriff (PDF)

P52-8 Resistant hypercalcemia of malignancy: A management conundrum

Annals of oncology, 2021-07, Vol.32, p.S357-S357

2021

Volltextzugriff (PDF)

Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials

Annals of oncology, 2017-11, Vol.28 (11), p.2780-2785

2017

Volltextzugriff (PDF)

2205P Tumor-infiltrating lymphocytes score possesses a relation with adjuvant chemo-immunotherapy benefit and cellular morphology in large-cell neuroendocrine carcinoma

Annals of oncology, 2023-10, Vol.34, p.S1139-S1139

2023

Volltextzugriff (PDF)

1220P A randomized phase II trial of anlotinib plus docetaxel vs docetaxel for second-line treatment of EGFR-negative NSCLC (ALTER-L018)

Annals of oncology, 2021-09, Vol.32, p.S970-S970

2021

Volltextzugriff (PDF)

230P Molecular profiling and clinical characteristics of Chinese patients with prostate cancer

Annals of oncology, 2020-11, Vol.31, p.S1331-S1331

2020

Volltextzugriff (PDF)

585P Fragmentomics early detection assay leading to potential clinical benefits in colorectal cancer

Annals of oncology, 2023-10, Vol.34, p.S426-S426

2023

Volltextzugriff (PDF)

Clinical and molecular characteristics of ALK-rearranged Chinese lung cancer patients

Annals of oncology, 2018-11, Vol.29, p.ix114-ix114

2018

Volltextzugriff (PDF)

Efficacy and safety of intermittent dosing schedule of apatinib for advanced gastric cancer in second-line setting

Annals of oncology, 2019-07, Vol.30, p.iv22-iv22

2019

Volltextzugriff (PDF)

A model based adjustment for tumor mutational burden across different tumor types

Annals of oncology, 2017-10, Vol.28, p.vii13-vii13

2017

Volltextzugriff (PDF)

558P Molecular subtyping endometrial carcinoma in Chinese population applying an NGS-based classifier and its association with prognosis

Annals of oncology, 2022-09, Vol.33, p.S803

2022

Volltextzugriff (PDF)

1 – 25 von 180

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAnnals Of Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(180)

Publikationsform

Artikel
(180)

Sprache

Englisch
(180)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Oncology
(14)
Science & Technology
(14)
Humans
(12)
Adult
(6)
Female
(6)
Male
(6)
Middle Aged
(6)
Original
(5)
Treatment Outcome
(5)
Aged
(4)
Biomarkers, Tumor - Genetics
(4)
Follow-Up Studies
(4)
Prognosis
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Colorectal Neoplasms - Drug Therapy
(3)
Colorectal Neoplasms - Genetics
(3)
Kaplan-Meier Estimate
(3)
Polymorphism, Single Nucleotide
(3)
Retrospective Studies
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China

Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer

73P A novel nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer

Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial

NGS-based profiling reveals a critical contributing role of somatic D-loop mtDNA mutations in HBV-related hepatocarcinogenesis

284P Gut microbiota mediates the protective effects of resveratrol against the intestinal barrier dysfunction in non-alcoholic steatohepatitis induced by high-fat diet

Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma

Phase I dose escalation and expansion study of golidocitinib, a highly selective JAK1 inhibitor, in relapsed or refractory peripheral T-cell lymphomas

180P Schwann cells promotes tumour progression in small cell lung cancer

226P Prognosis stratification of immunotherapy by a mutational signature in urothelial carcinoma

Biomarker assessment of the CBCSG006 trial: a randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer

Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches

103P Comprehensive genomic landscape in younger and older Chinese patients with colorectal cancer

1482P Comprehensive molecular profiling and identification of prognostic factors in patients with resectable esophageal squamous cell carcinoma

P53-5 Severe hypercalcemia in renal cell carcinoma: The diverse manifestations of genitourinary malignancies

P52-8 Resistant hypercalcemia of malignancy: A management conundrum

Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials

2205P Tumor-infiltrating lymphocytes score possesses a relation with adjuvant chemo-immunotherapy benefit and cellular morphology in large-cell neuroendocrine carcinoma

1220P A randomized phase II trial of anlotinib plus docetaxel vs docetaxel for second-line treatment of EGFR-negative NSCLC (ALTER-L018)

230P Molecular profiling and clinical characteristics of Chinese patients with prostate cancer

585P Fragmentomics early detection assay leading to potential clinical benefits in colorectal cancer

Clinical and molecular characteristics of ALK-rearranged Chinese lung cancer patients

Efficacy and safety of intermittent dosing schedule of apatinib for advanced gastric cancer in second-line setting

A model based adjustment for tumor mutational burden across different tumor types

558P Molecular subtyping endometrial carcinoma in Chinese population applying an NGS-based classifier and its association with prognosis

Aktive Filter

Suchergebnisse filtern